Hilltop National Bank Buys 17,440 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Hilltop National Bank raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 8,000.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,658 shares of the company's stock after purchasing an additional 17,440 shares during the period. Hilltop National Bank's holdings in GE HealthCare Technologies were worth $1,381,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC boosted its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after buying an additional 251 shares during the period. Fred Alger Management LLC purchased a new stake in GE HealthCare Technologies during the 2nd quarter valued at about $26,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $26,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in GE HealthCare Technologies in the second quarter valued at approximately $31,000. Institutional investors own 82.06% of the company's stock.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Stock Down 1.7 %

NASDAQ:GEHC traded down $1.50 during mid-day trading on Friday, hitting $84.76. 3,791,919 shares of the company's stock were exchanged, compared to its average volume of 3,454,140. GE HealthCare Technologies Inc. has a one year low of $71.31 and a one year high of $94.55. The business has a fifty day moving average price of $82.25 and a 200 day moving average price of $84.10. The company has a market cap of $38.72 billion, a PE ratio of 23.29, a P/E/G ratio of 2.90 and a beta of 1.11. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the business posted $0.99 EPS. The firm's quarterly revenue was up .9% compared to the same quarter last year. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies's payout ratio is presently 3.85%.

Analyst Upgrades and Downgrades

GEHC has been the topic of several recent analyst reports. Evercore ISI raised their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a research note on Wednesday. Stifel Nicolaus upped their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research report on Monday, September 30th. Finally, Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.